Clinical Relevance Of Fatigue As A Residual Symptom In Major Depressive Disorder
Research Summary | June 9, 2015
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
Key Messages Fatigue is a common residual symptom of major depressive disorder (MDD) and may be an adverse prognostic indicator. Certain fatigue-specific measures have been shown to be reliable and sensitive tools for the measurement of residual fatigue in patients with depression. Although mechanisms are unknown, it has been postulated that norepinephrine, dopaminergic neurotransmission, and…
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.